Reaction profile

The FDA adverse-event record for attractiveness to males

Name: Attractiveness to males - FDA Animal Adverse Reaction
Creator: PlainBreed
License: https://open.fda.gov/license/

34 FDA reports name attractiveness to males, a lower-volume reaction in the CVM extract (VeDDRA 2061). Plate stamps and neighbourhood peers follow.

#1927 of 2,481
by report volume (all reactions): 34
reports citing this reaction: 8.8%
death-coded share: Dog
most-affected species

Compiled by PlainBreed

Verify with FDA CVM →

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Attractiveness to males has 34 reports now versus 33 in that prior snapshot: 1 more (3.0%).

Report change: +1
Death-coded reports: +0
Death-coded share: −0.3 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Attractiveness to males changes

FDA AER · VeDDRA plate

Code 2061 VOL-TRACE

VOL-TRACE · DEATH-PAR · LOWER-Q · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

VOL-TRACE 34 reports
DEATH-PAR 8.8%
LOWER-Q #1927/2481
PHOTO-FINISH Encephalopathy NOS
SPECIES-DOG Dog · 32
DRUG-LEAD Estriol Tablets · 29
DESK-WIDE 20 breeds
BOOK-FULL 8/8 fields

Nearest volume peer: Encephalopathy NOS (±0 reports)

Instrument codes from this reaction’s FDA CVM adverse-event extract: volume band, death-coded share, corpus rank, photo-finish peer, lead species, lead drug, breed desk, and book completeness. Not a clinical diagnosis.

Lower-volume neighbourhood around Attractiveness to males

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

FDA AER report volume · neighbourhood around Attractiveness to males

What the FDA AER plate says about Attractiveness to males

Signature read: 3 death-coded reports is a thin tail count for Attractiveness to males in the CVM extract. Report volume is lower-third scale: 34 named reports in the openFDA extract. 3 of 34 reports were death-coded (8.8% of named reports, not a population mortality rate). Nearest volume peer: Encephalopathy NOS (±0 reports). Lead species Dog (32). Lead co-reported drug Estriol Tablets (29).

Read these counts as reporting volume, not risk: per our methodology, Lead co-reported drug Estriol Tablets appears in filings alongside this reaction; that is association, not causation. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 32

Cattle 2

Breeds Most Affected

Crossbred Canine/dog 8

Terrier - Yorkshire 2

Doberman Pinscher 2

Poodle - Miniature 2

Pug 2

Sheepdog - Shetland 1

Cattle (other) 1

Retriever - Labrador 1

Terrier - Fox (unspecified) 1

Holstein-Friesian also known as Holstein 1

Associated Drugs

Estriol Tablets 29

Trilostane 2

Estriol 1

Progesterone; Estradiol Benzoate 1

Melengestrol Acetate 1

Estradiol Benzoate; Trenbolone Acetate 1

Bedinvetmab 1

What to do with this reaction

Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
Browse the full reaction directory to compare report counts across reaction types. All reactions

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Attractiveness to males (#1927 of 2,481 by report volume); death-coded 8.8%. PlainBreed reaction plate · death-coded report count stamp 3 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →